For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Civil Litigation

Nov. 26, 2024

Jury awards $292M in false advertising case

A jury in San Francisco found that cancer test maker Natera made false and misleading claims about rival Guardant's product.

A federal jury in San Francisco has awarded $292.5 million in damages to biotechnology company Guardant Health Inc. in its false advertising dispute with rival Natera Inc. over claims related to the efficacy of its colorectal cancer test.

Natera said it will ask the judge to overturn the verdict.

Aside from the damages awarded, the case was notable for a dispute over Natera's expert witness testimony and the conduct of one of the company's attorneys with Quinn Eman...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Sign up for Daily Journal emails



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.